These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21855119)

  • 1. Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992-2005: a population-based study.
    Akhtar-Danesh N; Elit L; Lytwyn A
    Gynecol Oncol; 2011 Nov; 123(2):192-5. PubMed ID: 21855119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in the relative survival among women with cervical cancer in Canada: a population-based study.
    Akhtar-Danesh N; Elit L; Lytwyn A
    Int J Gynecol Cancer; 2012 Sep; 22(7):1208-13. PubMed ID: 22854653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.
    Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ
    Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature.
    Blake EA; Kodama M; Yunokawa M; Ross MS; Ueda Y; Grubbs BH; Matsuo K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():97-105. PubMed ID: 25668134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year relative survival for epithelial ovarian cancer.
    Baldwin LA; Huang B; Miller RW; Tucker T; Goodrich ST; Podzielinski I; DeSimone CP; Ueland FR; van Nagell JR; Seamon LG
    Obstet Gynecol; 2012 Sep; 120(3):612-8. PubMed ID: 22914471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status.
    Kotsopoulos J; Rosen B; Fan I; Moody J; McLaughlin JR; Risch H; May T; Sun P; Narod SA
    Gynecol Oncol; 2016 Jan; 140(1):42-7. PubMed ID: 26556769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
    Wong KH; Mang OW; Au KH; Law SC
    Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
    Vogel TJ; Goodman MT; Li AJ; Jeon CY
    Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group.
    Altman AD; Lambert P; Love AJ; Turner D; Lotocki R; Dean E; Popowich S; Nachtigal MW
    Int J Gynecol Cancer; 2017 Oct; 27(8):1637-1644. PubMed ID: 28704327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
    O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
    J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
    Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
    JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
    Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
    APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer?
    Lydiksen L; Jensen-Fangel S; Blaakaer J
    Gynecol Oncol; 2014 Jun; 133(3):454-9. PubMed ID: 24726613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
    Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
    J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
    Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
    J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.
    Lee JY; Kim S; Kim YT; Lim MC; Lee B; Jung KW; Kim JW; Park SY; Won YJ
    BMC Cancer; 2018 May; 18(1):601. PubMed ID: 29843633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study.
    Akhtar-Danesh N; Elit L; Lytwyn A
    Gynecol Oncol; 2014 Aug; 134(2):314-8. PubMed ID: 24875124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.